Cardiac Science Announces Third Quart...(tal current assets ...),Health

Date:11/9/2009

tal current assets 88,789 102,522 Other assets 358 428 Machinery and equipment, net of accumulated depreciation 7,951 6,994 Deferred income taxes - 28,452 Intangible assets, net of accumulated amortization 28,672 31,278 Investments in unconsolidated entities 664 534 --- --- Total assets $126,434 $170,208 ======== ======== LIABILITIES AND EQUITY Current Liabilities: Accounts payable 11,885 12,711 Accrued liabilities 12,568 13,535 Warranty liability 3,861 3,796 AED field initiative liability 18,500 - Deferred revenue 7,787 7,918 ----- ----- Total current liabilities $54,601 $37,960 Deferred income taxes 5,376 - Total liabilities $59,977 $37,960 ------- ------- Equity: Cardiac Science Corporation shareholders' equity 65,422 131,703 Noncontrolling interests 1,035 545 ----- --- Total equity 66,457 132,248
'/>"/>

SOURCE Cardiac Science Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Related medicine technology :

1. Personalized Medicine - The Genomic Revolution in Cardiac Care
2. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
6. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
7. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
10. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
11. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery